CREDIT ACCEPTANCE CORP (CACC): what the price assumes

boothcheck covers CREDIT ACCEPTANCE CORP (CACC) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-25.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/CACC

Headline

FieldValue
TickerCACC
CompanyCREDIT ACCEPTANCE CORP
Sector / IndustryFinancial Services
Current price$604.72/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)17.1%
Operating margin today27.9%
Margin compression (value-band)-10.8pp
Multiple paid12x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

How unusual the bet is: n/a

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.95x4justifies
Earnings0.79x4justifies
Relative0.64x4justifies
Growth0.50x3justifies

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 5.9%); the inversion above states its own rate.

Per-Model Detail (n=15)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$3972.390.15xyesFCF base $1.2B, growth 3% (input: historical growth), terminal g 2.6%, WACC 5.9%, 5yr projection
DCF Exit MultipleGrowth$1217.570.50xyesExit EV/EBITDA: 16133.6x / 16135.6x / 16137.6x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$595.441.02xyesP/E 12x (static sector reference · 2026-04), scenarios: 10.1x / 12.0x / 13.9x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$522.701.16xyesBV/sh $153.06, ROE (TTM) 31.6%, ke 9.3%
Two-Stage Excess ReturnAsset$1006.990.60xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$551.571.10xyesRev $2.3B, growth 3% (input: historical growth; tapered), Terminal P/S: 2.3x / 2.7x / 3.1x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$1587.600.38xyesEPS $45.36, growth 35% (input: historical EPS growth), PEG=0.36 (Undervalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAsset$803.180.75xyesBV $153.06 + 5yr PV of (ROE (TTM) 31.6% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$395.241.53xyes√(22.5 × EPS $45.36 × BVPS $153.06) — Graham's conservative floor
EV/EBITDA RelativeRelativeno
FCF YieldEarnings$788.350.77xyesFCF $1221.1M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$741.380.82xyesSBC-adj FCF $1.18B (FCF $1.22B − SBC $0.05B) capitalized at Kₑ
Ben Graham FormulaEarnings$1463.620.41xyesEPS $45.36 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelative$673.290.90xyesRevenue $2.33B × sector P/S 3.0x
PEG Fair ValueRelative$1701.000.36xyesEPS $45.36 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$490.381.23xyesEPS $45.36 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net debt$5.0b
Net debt / NOPAT (after-tax)9.58x
Net debt / operating income (pre-tax)7.73x
Interest coverage1.5x
Share count CAGR (buyback)-5.6%
Burning cashno

Bullet Takeaways

Bull Case

The market is paying about 13 times trailing pre-tax operating profit here, roughly what it pays for lenders it expects to plod along. The economics underneath do not look like plodding. Over the trailing year the company earned close to a 30% return on its book equity, against a cost of equity in the low nines, and it did that in a corner of consumer credit where most balance sheets refuse to compete at all.

The reason it can is structural, and it starts with who takes the first loss. Credit Acceptance mostly does not underwrite the borrower and hope. It advances cash to the dealer against a pool of loans, services the paper, and pays the dealer the remainder only after the advance and the servicing fee have been recovered from actual collections. The dealer's profit therefore depends on whether the dealer's own customers pay. Under the second of its two arrangements the company takes the paper outright, and the FY2025 10-K states the mechanics in one line: Under the Purchase Program, we buy the Consumer Loans from the Dealers (referred to as a "Purchased Loan") and keep all amounts collected from the consumer. Access to that arrangement is rationed, granted to dealers that have already assigned at least 50 loans through the shared-risk program or that are franchise dealerships. The company lets dealers earn their way into the better deal.

What makes the model durable is the feedback loop bolted onto it. Every month, and every year in print, the company checks its own forecasts against what borrowers actually paid. The 10-K describes it plainly: We monitor and evaluate Consumer Loan performance on a monthly basis by comparing our current forecasted collection rates to our initial expectations. And it explains why that comparison is the whole game: By comparing our current expected collection rate for each Consumer Loan with the rate we projected at the time of assignment, we are able to assess the accuracy of our initial forecast. A subprime lender that publishes the scorecard on its own credit judgment, vintage by vintage, is handing investors the one disclosure that matters most and is hardest to fake. On the newest vintage the scorecard reads well: the 2025 assignments were revised up during the year.

Capital allocation has been the quiet compounder. The share count has come down at roughly 6.5% a year on average between March 2022 and March 2026. Pair a shrinking denominator with a return on equity near 30% and book value per share, $138.22 at the latest count, climbs on two engines at once. Nothing here depends on a new product or a new market. It depends on the company continuing to do what it does and buying back the rest.

Against its cohort the profitability comparison is favorable rather than merely adequate. OMF converts about 18.7 cents of each revenue dollar into net profit on $4.252 billion of revenue; ALLY converts about 16.5 cents on $8.475 billion; ENVA, growing faster than either at 17.5%, converts about 10 cents. Credit Acceptance converts a shade under 20 cents on a revenue base a fraction the size of ALLY's. The bull argument is not that this is a growth company. It is that a business earning these returns, shrinking its own share count, and priced where the value-based methods already land does not need growth to work.

Bear Case

Everyone with a balance sheet wants this business back. The FY2025 10-K names the field without flinching: automobile financing is large and highly competitive. The market is currently served by "buy here, pay here" dealerships, banks, captive finance affiliates of automobile manufacturers, credit unions, and independent finance companies both publicly and privately owned. Many of these companies are much larger and have greater resources than us. ALLY alone carries $8.475 billion of revenue, growing 9.7%, against a subject revenue base of roughly $2.3 billion; OMF carries $4.252 billion growing 8.8%; LC is growing at 25.4%. Bigger competitors in this market do not usually attack on the interest rate, because the borrower is not shopping on rate. They attack on how much cash the dealer gets up front, and the 10-K spells out exactly what that costs: Increasing advance rates on Loans has the impact of reducing the return on capital we expect to earn on Loans. Competitive pressure arrives here as a slow leak in returns, not as a visible price war.

The leak may already be showing. Dollar volume of consumer loans assigned fell to $3,856.1 million in 2025 from $4,147.8 million in 2023, while the number of active dealers on the platform rose over the same span. More storefronts, less business through each of them, is what a company looks like when it is holding onto distribution by adding partners faster than it is losing volume.

Now put that against what the price requires. At $574.72 the market is underwriting company-wide operating growth running at roughly the 25% annual ceiling the balance sheet can fund out of its own earnings, and holding there for something close to seven years. Revenue grew about 4.6% over the trailing year. Of comparable fast-growing companies that have reached that pace, only about one in five sustained it for seven years. If that assumption reverts toward the delivered rate, nothing about the business breaks, but the multiple the market is willing to pay compresses toward where the peer-multiple approaches already sit, which is well under today's price.

The mechanism that would cause the reversion is written into the disclosure. This company's earnings are a forecast until the loans finish paying, and the 10-K says so: There can be no assurance that our forecasts will be accurate or that Consumer Loan performance will be as expected. The record is mixed on exactly that point. Collection rates on the 2022, 2023 and 2024 assignments were all revised down during 2025. Three consecutive marked-down vintages is not a crisis, but it is the specific pattern that turns a reported return on equity into a number that shrinks in arrears.

Funding is the other pressure point, and it is tighter than the profitability suggests. Pre-tax operating income covers the interest bill only about 1.3 times, which for a lender is not a distress signal so much as a statement of what the business actually is: borrowed money is the raw material, and the spread between what it costs and what borrowers pay is the product. Squeeze that spread and there is little cushion. The 10-K is explicit about the dependency: If our various financing alternatives were to become limited or unavailable, we may be unable to maintain or grow Consumer Loan volume at the level that we anticipate and our operations could be materially adversely affected.

Sitting behind all of it is a regulatory file that has been open for a decade. The 10-K discloses that we received a subpoena from the Attorney General of the State of Maryland restating most of the requests contained in the March 18, 2016 and April 3, 2020 subpoenas, making additional requests, and expanding the inquiry to include 41 other states. A multi-state inquiry into how a subprime lender originates and collects is not the kind of thing that resolves into a rounding error, and its cost is not in any forecast the company publishes.

Valuation

Work backward from $574.72 and the assumption becomes specific. The market is capitalizing the company at roughly 13 times its trailing pre-tax operating profit, and that multiple holds together only if company-wide operating growth runs at about the 25% a year ceiling the balance sheet can self-fund, and keeps running there for close to seven years. Only about one in five comparable fast-growers has sustained that pace over such a span. Set against a company whose revenue grew about 4.6% over the trailing year, that is a demanding path, and it is the one thing in this report that is genuinely stretched.

The valuation approaches themselves are unusually close to agreement, which is not what a stretched multiple usually looks like. The price sits about 6% above where the asset-value methods land and about 4% above the earnings-power methods, and both the peer-multiple approaches and the forward-growth approaches reach above today's price. Every lens supports the price at some level. Read together, this prices as a value-supported financial rather than a growth bet, with the demanding assumption sitting in the growth path rather than in the level.

The excess-return approach is worth naming because it is the one built for a lender. It starts from book value of $138.22 a share, adds a fixed run of years in which the trailing return on equity near 30% keeps beating the 9.3% cost of equity, then lets that advantage converge away. Even with the convergence, it lands above the current price. The most conservative asset-based screen, the one that multiplies earnings by book value and takes the square root of the product, lands well under the price, which is the honest boundary on the downside case rather than a target.

What has to be true, in plain terms, is that the underwriting keeps working. This is not a margin story. It is a collections story, and the collections are a forecast until they are cash. The FY2025 10-K gives the running scorecard: forecasted collection rates improved for Consumer Loans assigned in 2020 and 2025, declined for Consumer Loans assigned in 2022 through 2024. The direction of the newest vintage matters more for the forward case than the level of any trailing ratio.

On cohort position, the company sits in the lower half of the peer multiple range while out-earning most of the group per revenue dollar. OMF turns about 18.7 cents of revenue into net profit; ALLY about 16.5 cents; ENVA about 10 cents while growing 17.5%. The subject converts just under 20 cents. What the market is discounting is not the current profitability but its persistence.

The balance sheet is the constraint that decides how much of that persistence the company controls. It is not burning cash, and the share count has fallen at roughly 6.5% a year since March 2022, which is buyback deployment showing up where it cannot be disguised. But pre-tax operating income covers interest only about 1.3 times, and the filed volume table shows the raw material shrinking: $3,856.1 million of loan assignments in 2025 against $4,147.8 million in 2023. A lender whose cost of funds rises faster than its advance discipline improves loses on both sides of the spread at once, and that, rather than any multiple, is what the seven-year assumption is really resting on.

Catalysts

The next hard information arrives at the end of July. The company is scheduled to report its June quarter on July 31, 2026, the first print that will show whether the 2026 assignment run rate has turned up against the volume decline visible in the FY2025 filed disclosure. Three days before it, the finance function changes hands: Joe Billante becomes chief financial officer effective July 27, 2026, succeeding a retiring incumbent.

That handover is not ceremonial at a company built on borrowed money. Also in June 2026 the company extended its revolving secured line of credit facility, the kind of housekeeping that only becomes news when it fails to happen. With interest cover near 1.3 times pre-tax operating income, the terms on which this balance sheet renews its funding do more to the forward earnings path than any single quarter of loan volume, and the incoming finance chief inherits that job first.

The prior quarter was reported on May 5, 2026. Between then and the July print, the item worth tracking is the vintage table rather than the headline: whether the 2025 and 2026 assignments hold their improved collection forecasts, or whether they follow 2022 through 2024 into revision.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

company earnings calendar, July 2026 · company press release via GlobeNewswire, June 2026 · Q1 2026 earnings release, May 5, 2026

View the full interactive CACC report on boothcheck